To see prescription patterns and effectiveness of drugs used in Attention deficit hyperactivity disorder.
- Conditions
- Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type
- Registration Number
- CTRI/2022/08/045036
- Lead Sponsor
- Dr Dnyaneshwar G Kurle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
A. Criteria for assessing prescription pattern, adverse drug reaction, awareness, cost:
1. Patient with the age less than 16 years diagnosed with ADHD according DSM 5 of
either sex will be included.
2. Patients receiving drug treatment for ADHD.
3. Patients & legal authorized representative willing to give informed consent &
participate in the study.
Inclusion criteria for assessing effectiveness of drugs used in ADHD:
1. Patient with the age from 6 to 16 years diagnosed with ADHD according DSM 5 of
either sex will be included.
2. Patients receiving single drug either methylphenidate or atomoxetine will be
included.
3. Patients & legal authorized representative willing to give informed consent &
participate in the study.
4. Patient who are able to understand and do the computerised psychometric test
Criteria for assessing prescription pattern, adverse drug reaction, awareness, cost:
Patient not satisfying inclusion criteria will be excluded from the study.
Criteria for assessing effectiveness of drugs used in ADHD:
1. Patients with other known neurological or gross organic diseases or other psychiatric
disorder or substance abuse.
2. Patient taking psychoactive medications other than the study drugs.
3. Patients with motor tics.
4. Patient who are not able to understand or follow the instructions for doing the tes
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method